Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001450324-21-000008

CEO & President acquired 10,204 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

EQUELS THOMAS K. · CEO & President

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-11-19 Grant or award : show line 1 in the form +10,204 $1.47 $15,000 244,605 D
Loading xslF345X03/primary_doc.xml…